Savara, Inc. · NASDAQ:SVRA
Bain Capital Life Sciences Fund II, L.P. reported a 9.99% stake in Savara, Inc. (Schedule 13D/A)
Event Mar 25, 2025 · Filed Mar 27, 2025
Bain Capital Life Sciences Fund II, L.P. reported a 9.99% stake in Savara, Inc., 17,600,621 shares, with active intent on Mar 25, 2025. Filed Mar 27, 2025 (Schedule 13D/A).
- Stake
- 9.99%
- Shares
- 17,600,621
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Bain Capital Life Sciences Fund II, L.P. | 9.99% | 17,600,621 |
| BCIP Life Sciences Associates, LP | 9.99% | 17,600,621 |
| BCLS II Investco, LP | 9.99% | 17,600,621 |
Source
Related
- Savara, Inc.
- BCLS II Equity Opportunities, LP
- Savara, Inc. shareholders
- Form 4 · Parker Braden C. · Sep 25, 2026
- Schedule 13G/A · Farallon Capital Management, L.L.C. · Aug 14, 2026
- Form 4 · Lutz Robert Matthew · Jul 24, 2026
- Form 4 · Lowrance David L · Jun 22, 2026
- Schedule 13G/A · TCG Crossover GP I, LLC · Feb 17, 2026